Chapter 331 Securing the Cure

• One by one, patients underwent trials with the new medicine. While some severe cases ended in death, most saw the virus eliminated. The lingering issue was the aftereffects—these ranged from mild to life-altering.
• The Research Institute was in a tough spot. Should it report the results honestly? Medicine was running low, and teams sent out to source more had had no luck. They couldn't independently decide whether to focus on quality or mass production.
• No one wanted to lose hope.